Number of the records: 1
kofeín
SYS d002110 LBL 00000nz--a2200000o--4500 005 20250606214716.9 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D03.132.960.175 065 $a D03.633.100.759.758.824.175 066 $a 01 $c 03 150 $a kofeín $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000697 $Y Central Nervous System Stimulants $w P $a stimulanciá centrálneho nervového systému 550 $7 sllk_us_auth*d010726 $Y Phosphodiesterase Inhibitors $w P $a inhibítory fosfodiesteráz 550 $7 sllk_us_auth*d058915 $Y Purinergic P1 Receptor Antagonists $w P $a antagonisty purinergných receptorov P1 550 $7 sllk_us_auth*d003069 $Y Coffee $w b $a káva 680 9-
$i A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. $2 eng 750 -2
$a Caffeine $2 eng 980 $x M
Number of the records: 1